Skip to main content

Drug Use

2
Pipeline Programs
4
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
3 programs
1
1
Quit Using Drugs Intervention TrialPhase 2/31 trial
Art MessagingPhase 21 trial
Quit Using Drugs Intervention TrialN/A1 trial
Active Trials
NCT01942811Completed134Est. Feb 2014
NCT00862238Completed156Est. Mar 2011
NCT01942876Completed411Est. Feb 2013
Kimia Therapeutics
Kimia TherapeuticsCA - Berkeley
2 programs
Acyclovir 200 MGN/A1 trial
Furosemide 40 mgN/A1 trial
Active Trials
NCT04988646Completed56Est. Apr 2020
NCT04982874Completed24Est. Jan 2020
Kalbe
KalbeIndonesia - Jakarta
1 program
Omeprazole 20 mg CapsulesN/A1 trial
Active Trials
NCT05849883Completed36Est. Feb 2021
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Retention VideoN/A1 trial
Active Trials
NCT03885024Completed850Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsQuit Using Drugs Intervention Trial
Angeles TherapeuticsArt Messaging
KalbeOmeprazole 20 mg Capsules
Oregon TherapeuticsRetention Video
Kimia TherapeuticsAcyclovir 200 MG
Kimia TherapeuticsFurosemide 40 mg
Angeles TherapeuticsQuit Using Drugs Intervention Trial

Clinical Trials (7)

Total enrollment: 1,667 patients across 7 trials

NCT01942876Angeles TherapeuticsQuit Using Drugs Intervention Trial

Preventing Drug Use in Low Income Clinic Populations

Start: Jan 2011Est. completion: Feb 2013411 patients
Phase 2/3Completed
NCT00862238Angeles TherapeuticsArt Messaging

An Arts Intervention for Drug-Using Homeless Youth

Start: Apr 2008Est. completion: Mar 2011156 patients
Phase 2Completed
NCT05849883KalbeOmeprazole 20 mg Capsules

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

Start: Dec 2020Est. completion: Feb 202136 patients
N/ACompleted
NCT03885024Oregon TherapeuticsRetention Video

The Peer-Based Retention of People Who Use Drugs in Rural Research

Start: Aug 2020Est. completion: Jul 2023850 patients
N/ACompleted
NCT04988646Kimia TherapeuticsAcyclovir 200 MG

Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject

Start: Feb 2020Est. completion: Apr 202056 patients
N/ACompleted
NCT04982874Kimia TherapeuticsFurosemide 40 mg

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Start: Dec 2019Est. completion: Jan 202024 patients
N/ACompleted
NCT01942811Angeles TherapeuticsQuit Using Drugs Intervention Trial

BiNational Quit Using Drugs Intervention Trial

Start: Feb 2013Est. completion: Feb 2014134 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.